Pharmaceutical , Medical Device, Cosmetic, Food Regulatory Compliance Expert

Technical Consultant #2228


  • Regulatory strategy, pathways and gap analyses.
  • Regulatory submissions and applications for diverse product types to global regulatory agencies: Health Canada, US FDA and EU EMA (CTA, IND, IDE, DMF, NDS, SNDS, ANDS, SANDS, DIN, NDA, NDA 505(b)(2), BLA, ANDA, PAS, CBE, CBE-30, 510(k), PMA, HUD, HDE, Class II, III and IV Device License Applications, ITA, MAA, Type I and II variations, Technical File, PLA, Amendments, Notifications, and CNF).
  • Regulatory compliance product areas: Prescription brand pharmaceutical and biologic, generic, biosimilar, orphan designation, radiopharmaceutical and over the counter drugs, medical devices, natural health products, traditional herbal medicines, dietary supplements, cosmetics, and food.
  • Quality compliance for multiple jurisdictions including Canada, U.S.A. and E.U. (GLP, GCP, GMP, GVP quality systems design and management for companies across the global supply chain; batch documentation; annual product quality reviews; process, computer system and package validation; ISO 13485:2003 certification for Class II, III and IV medical devices; technical quality agreements; regulatory agency audit support; supplier qualifications; self-inspections, and personnel training).
  • Drug and medical device establishment licensing and facility registration.
  • Chemistry, Manufacturing, and Controls (CMC).
  • Label and marketing material and social media compliance.
  • Clinical trials: (IRB / ERB consulting; study design strategy; product labeling; investigator brochure and informed consent form; case report forms; study protocol, amendments and report; CTA, IND, IDE applications; registration with U.S. clinical trials, government; safety reporting; good clinical practice audit).
  • Safety PharmacoVigilance, reporting and risk management for drugs and medical devices (ICSR, SAE, SADR, DSUR, PSUR, PBRER, RMP, MDR, HCP and public communications).
  • Medical information and medical writing.

Expert Witness Experience

  • Regulatory expert opinion support for corporations (including legal cases due to serious adverse events experienced by patients / consumers involving medical devices and cosmetics).


Undisclosed Company, Regulatory Consultant, 2008 - Current


Sanofi Pasteur

  • NDS, NDA, BLA (hexavalent combination vaccine)
  • International submissions (e.g. Israel) - Chemistry Manufacturing and Controls (CMC)
  • U.S. Prior Approval Supplements (PAS)
  • E.U. variations

Gopaldas Visram and Co. Ltd.

  • Drug Master File (DMF)

Sigmacon LifeSciences Inc.

  • Drug Notification Filings (DNFs)
  • Drug Establishment License (DEL) application, amendments and annual reviews
  • Quality system upgrades
  • Quality reviews - Master manufacturing and packaging documents, labeling, stability data, returns, re-packaged drug product, Out of Specifications (OOS), Certificates of Compliance (CoC), Certificates of Analyses (CoA), and Certificates of Manufacture (CoM)
  • Batch releases
  • Annual Product Quality Reviews (APQRs)
  • Attained compliance rating at Health Canada, GMP audits
  • Self-inspections of virtually run manufacturer including contract manufacturing facility (Actavis, then Cobalt Pharmaceuticals)
  • Annual pharmacovigilance and drug safety reports


  • Premarket notifications [510(k)] for 2 device systems (Jintronix Rehabilitation System and Jintronix)
  • Design of Quality Management System (QMS) compliant to Health Canada and U.S. FDA
  • Facility registration support
  • Clinical study design consultation
  • Software risk hazard analyses, cybersecurity and validation consulting

Toshiba Medical Systems Corp.

  • Pre and post market regulatory activities for Toshiba's Medical Diagnostic Systems (Investigational Testing Authorization (ITA), medical device license applications and amendments).
  • Regulatory evaluations of device system changes
  • Software validation gap analyses

McArthur Medical Sales Inc.

  • Medical Device Establishment Licensing (MDEL) amendments and annual reviews
  • Health Canada audit - resolution of issues and closure
  • Medical device recall reporting
  • Complaint handling
  • Mandatory problem reporting

Beaver Medical Corp.

  • Medical Device Establishment License (MDEL) application
  • Quality system design and development

Andrew and David Wholesale Ltd.

  • Drug Establishment License application (DEL), amendments and annual reviews
  • Quality system design and development
  • Good Manufacturing Practices (GMP) training
  • Attained compliance rating at subsequent Health Canada GMP audits
  • Self-inspections
  • Computer system validation
  • Change management
  • Business goals support - assessment of requirements for DEL activity upgrade

Regulatory and Quality Consulting Firms

  • Laboratory validation project
  • Natural Health Product License Application (NHP PLA) research
  • Generic drug regulatory (ANDS compilations)
  • Regulatory publications on company website
  • Clientele projects
  • Regulatory expert opinions and legal support

EMD Inc. , Canada, (Merck KGaA affiliate)

Regulatory Submissions (Health Canada)

  • Natural Health Product License Applications (NHP PLA)
  • Product monograph regulatory updates
  • Support with various Drug Submissions (NDSs, SNDSs, CTAs, Clarifaxes)

Medical Information

  • Literature reviews and responses to several medical information requests including market competition analyses
  • Online literature databases used: Pubmed, Pubmed Central, MEDLINE, EMBASE, Cochrane
  • Global and preliminary response documents
  • Review of educational, promotional, advertising material for scientific, technical accuracy
  • Reviews, PDR Health, Thomson - Scientific, Pharma, Micromedex
  • Literature search training presentations

Drug Safety and Pharmacovigilance

  • Achieved perfect compliance rating (0 Observations) in Health Canada drug safety audit and maintained compliance in a subsequent corporate audit
  • Initiated internal QC audit trail of entire drug safety department
  • Substantially increased efficiency, organization and compliance of drug safety department
  • Preparation of global and Canadian drug safety and pharmacovigilance master files
  • Periodic Safety Update Reports (PSUR)
  • Product recalls - Writing health care professional and public communications
  • Benefit risk analyses, signal detection and label safety updates
  • Monthly compliance reporting
  • Writing of SOPs, work instructions, and personnel training
  • Assessment and reporting of adverse events to global Drug Safety Health Canada
  • Handled all types of adverse events: serious and non- serious, unsolicited and solicited e.g. Patient Services Consumer Call Centre, reports from literature, clinical and marketed products
  • Obtained patient consent For HCP follow up, medical confirmation HCP follow up requests
  • Liaised with Health Canada, global drug safety, patients, physicians, pharmacists and nurses

Revolymer (UK) Ltd.

  • Natural Health Product License Application (PLA) amendments and notifications
  • Regulatory change evaluations

Therapure Biopharma Inc.

  • Supported Quality Director with various global regulatory and quality requests

University of Western Ontario (UWO)

  • Quality system design for Good Laboratory Practices (GLP) compliance with Health Canada and U.S. FDA
  • GLP training of UWO Management, Study Director and Staff
  • GLP application package to Standards Council of Canada (SCC)

Voreia Industries Inc.

  • Cosmetic notifications to Health Canada for over 80 cosmetics
  • Label gap analyses for FDA compliance


  • Cosmetic label review and gap analyses (17 products)

Quotient Medical

  • Cosmetic label review and gap analyses

Bio-K International

  • Food regulatory and label compliance assessments (Canada)
  • Training of regulatory and quality team on safety reporting with respect to Dietary Supplements (USA) and Natural Health Products (Canada)

United Biopharmaceuticals Inc.

  • NHP regulatory gap analyses

Ingredient Depot

  • Facility GMP gap analyses and recommendations

Actavis Canada

  • Self-inspection

Gamma Dynacare Medical Laboratories

  • Self inspection

Ra Chem Pharma Ltd.

  • FDA quality observations resolution

Ind-Swift Laboratories Ltd.

  • FDA quality audit report

Honors & Publications


  • Post Graduate Diploma and Certificate. Regulatory, Quality and Clinical, Academy of Applied Pharmaceutical Sciences, Toronto, ON Canada
  • Online literature databases used: Pubmed, Pubmed Central, MEDLINE, EMBASE, Cochrane

Publications and Patents

  • Various regulatory articles published by global regulatory associations including Canada's CAPRA (NOC Magazine and bi-weekly e-Bulletins), USA's RAPS (Regulatory Focus) and UK's TOPRA (Regulatory Rapporteur).


  • B.S. Life Sciences Human Biology (With Honors), University of Toronto, Ontario, Canada
Save Resume #2228
to Contact Form?

You must first click "Yes" to save this resume

Submit Request

You have no Saved Resumes

Add resumes within our various Ares of Expertise by clicking "Add Resume(s)" below.

Add Resume(s)